{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Tarsus Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"TARS"},"Address":{"label":"Address","value":"15440 LAGUNA CANYON ROAD,SUITE 160, IRVINE, California, 92618, United States"},"Phone":{"label":"Phone","value":"+1 949 409-9820"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites."},"CompanyUrl":{"label":"Company Url","value":"https://www.tarsusrx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bobak Azamian","title":"Chairman, President & Chief Executive Officer"},{"name":"Chan Arthur","title":"VP-Medical Affairs"},{"name":"Sesha Neervannan","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}